Clinical Trials Logo

Clinical Trial Summary

The investigators are doing this research to find out if more careful assessment and elimination of potential risk factors of acute kidney injury (AKI) during the subject's perioperative period will reduce their chance of kidney damage and kidney damage related problems.


Clinical Trial Description

The purpose of the study is to investigate whether preventive measures for patients undergoing ventricular assist device (VAD) placement will reduce AKI occurrence, progression and associated complications.

Participants will be in the study for a total of 6 days (1 day prior to the surgery and 5 days after the surgery). The investigators will review the participant's medical record up to one year after surgery.

The study investigators will access the participant's electronic medical record 24 hours prior to the planned VAD implantation and review the participant's medication regimen and provide recommendations to the participant's primary care physician in an effort to minimize potential risks for AKI. There will be no intervention during the operation.

The clinical recommendations will cover the following:

1. Avoidance of potentially nephrotoxic agents.

2. Optimizing volume status (avoidance of volume overload or depletion)

3. Optimizing electrolytes and acid-base status

4. Minimizing IV contrast exposure when appropriate

5. Treating severe anemia

6. Optimization of hemodynamics (Mean arterial BP>65mmHg).

The investigators plan to compare the results of this study with the historical data in the same patient population in the years of 7/1/2015-6/30/2017. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03236831
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date April 11, 2017
Completion date February 17, 2019

See also
  Status Clinical Trial Phase
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Terminated NCT04051957 - Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury Phase 2
Completed NCT04985292 - Does Probiotic Supplementation Prevent Kidney Injury During Strenuous Physical Exercise? N/A
Completed NCT04933604 - LPN in Patients With High-complex Renal Tumors
Recruiting NCT05229328 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
Completed NCT02242006 - Antimicrobial Pharmacokinetics in Critically Ill Adults During Sustained Low Efficiency Dialysis (SLED)
Terminated NCT05747053 - Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Completed NCT03407573 - Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur N/A
Withdrawn NCT00793013 - Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation Phase 2
Not yet recruiting NCT06108765 - Acute Kidney Injury in Poly Trauma Patients
Recruiting NCT05155358 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
Completed NCT06008223 - Clinical Analysis of Vitamin B6 in Sepsis N/A
Completed NCT04869462 - DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
Recruiting NCT04626323 - Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease Phase 2
Active, not recruiting NCT02037321 - Meta-Analyses of the Effect of Vegetable Protein for Animal Protein on Cardiometabolic Risk N/A
Completed NCT00819871 - Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery N/A
Recruiting NCT05812755 - SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery Phase 4
Recruiting NCT04902846 - Immune Checkpoint Inhibitors Nephrotoxicity
Recruiting NCT04752293 - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Completed NCT03139123 - Prevalence of Hypotension Associated With Preload Dependence During Continuous Renal Replacement Therapy